Prothena Corp Public (PRTA) Non-Current Deferred Tax Liability (2013)

Prothena Corp Public's (PRTA) quarterly Non-Current Deferred Tax Liability came in at $201000.0 in Q2 2013.

Prothena Corp Public (PRTA) Non-Current Deferred Tax Liability (2013) Analysis & Trends

Prothena Corp Public's Non-Current Deferred Tax Liability history runs 1 years deep, the most recent figure standing at $201000.0 for Q2 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Prothena Corp Public	458.13 Mn	128.67 Mn	-

Download Data

Date	Value
Jun 30, 2013	201,000.00
Jun 30, 2013	201,000.00